InsiderClue
Insiders · Profile

Knight Jeff E.

Chief Dev. & Operating Officer at Crinetics Pharmaceuticals. Filing since 26 Jul 2022. CIK 0001881007

Company
Date
Role
Action
Shares
Amount
Of holding
CRNX Crinetics Pharmaceuticals, Inc.
8 Apr 2026
Chief Dev. & Operating Officer
Sold on a plan
85,163
$3.42M
44.7%
CRNX Crinetics Pharmaceuticals, Inc.
16 Mar 2026
Chief Operating Officer
Sold on a plan
9,911
$370.41K
8.1%
CRNX Crinetics Pharmaceuticals, Inc.
19 Mar 2025
Chief Operating Officer
Sold on a plan
7,162
$244.96K
7.6%
CRNX Crinetics Pharmaceuticals, Inc.
22 Nov 2024
Chief Operating Officer
Sold on a plan
501
$28.32K
1.0%
CRNX Crinetics Pharmaceuticals, Inc.
15 Jul 2024
Chief Operating Officer
Sold on a plan
27,000
$1.49M
34.3%
CRNX Crinetics Pharmaceuticals, Inc.
26 Jun 2024
Chief Operating Officer
Sold on a plan
956
$42.43K
1.8%
CRNX Crinetics Pharmaceuticals, Inc.
22 Mar 2024
Chief Operating Officer
Sold at will
32,359
$1.43M
38.1%
CRNX Crinetics Pharmaceuticals, Inc.
26 Jul 2022
Chief Operating Officer
Sold, plan not stated
1,152
$23.85K
18.9%
8 decisions on file.